Return to search

Additional regulatory review pathways can facilitate faster dossier approvals in South Africa

Magister Pharmaceuticae - MPharm / The objective of the study was to perform a comparative review of pathways, timelines and improvements of countries with markets that the South African Health Products Authority (SAHPRA) benchmark themselves against. Furthermore, this study intends to identify the factors that improved and accelerated submissions and approval process in investigated countries and potential introduction of these strategies into the South African market.

Identiferoai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:uwc/oai:etd.uwc.ac.za:11394/7878
Date January 2019
CreatorsMattew, Ilona
ContributorsJoubert, Jacques
PublisherUniversity of the Western Cape
Source SetsSouth African National ETD Portal
LanguageEnglish
Detected LanguageEnglish
RightsUniversity of the Western Cape

Page generated in 0.0021 seconds